ABSTRACT INTRODUCTION Although often self-limited, acute pericarditis recurs in up to 30% of patients. Recurrent pericarditis (RP) causes substantial morbidity (pain, fatigue, and impaired quality of life) and can lead to constriction. Traditional treatments have important limitations, including corticosteroid dependence, recurrent flares, and treatment-related adverse effects. Emerging targeted immunomodulators are therefore under active investigation.
Massimo Imazio
As seen in:
Nature,
Memory Studies,
heart,
MDPI,
Taylor & Francis Online,
JAMA (The Journal of the American Medical Association),
JAMA: Journal of the American Medical Association,
JACC (Journal of the American College of Cardiology),
Canadian Journal of Cardiology,
International Journal of Cardiology
and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Massimo
Contact Massimo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack